Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

O'Neill SC, Rini C, Goldsmith RE, Valdimarsdottir H, Cohen LH, Schwartz MD.

Psychooncology. 2009 Oct;18(10):1088-96. doi: 10.1002/pon.1467.

2.

Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer.

Brédart A, Kop JL, Depauw A, Caron O, Sultan S, Leblond D, Fajac A, Buecher B, Gauthier-Villars M, Noguès C, Flahault C, Stoppa-Lyonnet D, Dolbeault S.

Br J Cancer. 2013 Mar 19;108(5):1012-20. doi: 10.1038/bjc.2012.599. Epub 2013 Mar 5.

3.

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.

Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C.

J Clin Oncol. 2002 Jan 15;20(2):514-20.

PMID:
11786581
4.

Psychological distress and quality of life associated with genetic testing for breast cancer risk.

Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A.

Psychooncology. 2008 Aug;17(8):767-73.

PMID:
17992698
5.

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.

van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W.

J Clin Oncol. 2006 Aug 1;24(22):3672-7.

PMID:
16877736
6.

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?

Beran TM, Stanton AL, Kwan L, Seldon J, Bower JE, Vodermaier A, Ganz PA.

Ann Behav Med. 2008 Oct;36(2):107-16. doi: 10.1007/s12160-008-9060-9. Epub 2008 Sep 12.

PMID:
18787910
7.

Identification of patients at high risk of psychological distress after BRCA1 genetic testing.

Ertmański S, Metcalfe K, Trempała J, Głowacka MD, Lubiński J, Narod SA, Gronwald J.

Genet Test Mol Biomarkers. 2009 Jun;13(3):325-30. doi: 10.1089/gtmb.2008.0126.

PMID:
19405874
8.

Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.

Reichelt JG, Møller P, Heimdal K, Dahl AA.

Fam Cancer. 2008;7(3):245-54. doi: 10.1007/s10689-008-9182-z. Epub 2008 Jan 25.

PMID:
18219587
9.

Psychological impact of genetic testing in women from high-risk breast cancer families.

Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M, Brown J, Tucker K.

Eur J Cancer. 2002 Oct;38(15):2025-31.

PMID:
12376208
10.

Psychological impact of receiving a BRCA1/BRCA2 test result.

Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF.

Am J Med Genet. 2001 Jan 1;98(1):15-24.

PMID:
11426450
11.

Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.

Brédart A, Kop JL, De Pauw A, Caron O, Fajac A, Noguès C, Stoppa-Lyonnet D, Dolbeault S.

Breast. 2017 Feb;31:121-127. doi: 10.1016/j.breast.2016.10.024. Epub 2016 Nov 9.

PMID:
27837705
12.

Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim.

Friedman LC, Webb JA, Richards CS, Lynch GR, Kaplan AL, Brunicardi FC, Plon SE.

Genet Med. 1999 Mar-Apr;1(3):74-9.

PMID:
11336456
13.

Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.

O'Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H, Schwartz MD.

Am J Med Genet C Semin Med Genet. 2006 Nov 15;142C(4):251-9.

PMID:
17024668
14.

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

Maheu C, Bouhnik AD, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Berthet P, Fricker JP, Caron O, Luporsi E, Gladieff L, Julian-Reynier C.

Psychooncology. 2014 Apr;23(4):420-7. doi: 10.1002/pon.3435. Epub 2013 Oct 11.

PMID:
24127257
15.

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.

Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):445-55. doi: 10.1158/1055-9965.EPI-11-0991. Epub 2012 Feb 10.

16.

What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.

van Dijk S, Otten W, Timmermans DR, van Asperen CJ, Meijers-Heijboer H, Tibben A, Breuning MH, Kievit J.

Genet Med. 2005 Apr;7(4):239-45.

PMID:
15834241
17.

Hopefulness predicts resilience after hereditary colorectal cancer genetic testing: a prospective outcome trajectories study.

Ho SM, Ho JW, Bonanno GA, Chu AT, Chan EM.

BMC Cancer. 2010 Jun 11;10:279. doi: 10.1186/1471-2407-10-279.

18.

Coping with genetic testing for breast cancer susceptibility.

Dougall AL, Smith AW, Somers TJ, Posluszny DM, Rubinstein WS, Baum A.

Psychosom Med. 2009 Jan;71(1):98-105. doi: 10.1097/PSY.0b013e318190d7b4. Epub 2009 Jan 5.

PMID:
19124622
19.

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.

Schlich-Bakker KJ, Ausems MG, Schipper M, Ten Kroode HF, Wárlám-Rodenhuis CC, van den Bout J.

Breast Cancer Res Treat. 2008 Jun;109(3):507-14. Epub 2007 Aug 3.

20.

BRCA1/2 genetic testing uptake and psychosocial outcomes in men.

Graves KD, Gatammah R, Peshkin BN, Krieger A, Gell C, Valdimarsdottir HB, Schwartz MD.

Fam Cancer. 2011 Jun;10(2):213-23. doi: 10.1007/s10689-011-9425-2.

Supplemental Content

Support Center